Biolog-id completed phase one of deploying its value-chain optimization solution in a multi-state integrated delivery network in the southeast USA
Phase one focuses on a large medical center in the network
and includes inventory management of Platelets and Red Blood Cells in multiple locations
Atlanta, GA (September 30th, 2022) – Biolog-id has completed phase one of implementing its value-chain optimization solution in a large medical center and level II trauma center in North Carolina. This medical center is one of the largest in a multi-state delivery network in southeast USA that includes multiple medical centers, covering a large geographical area.
Within the blood bank, and in procedural areas across the hospital, the Biolog-id solution drives inventory management excellence through the automation of manual processes and through enhanced visibility and traceability of Platelets and Red Blood Cells.
“Managing blood products is a complex task in any large medical center, let alone in geographically dispersed care delivery networks,” said Troy Hilsenroth, CEO at Biolog-id. “This complexity is exactly where Biolog-id’s integrated platform is positioned to deliver compelling value and have a significant impact.”
The data accumulated demonstrates the impact of the Biolog-id solution and is being used to define the strategic expansion across additional medical centers within the network.
Biolog-id develops value-chain optimization solutions that create, collect, and consolidates high quality data to drive operational, commercial, and clinical impact for high-value high-impact health products. Biolog-id’s patented platform is used by multiple customers in the US, Europe, Middle East, India, and Asia Pacific. Biolog-id is owned by its founder and the Xerys Funds.